No spam - just the good stuff
Subscribe to our newsletter
First Name
(Required)
Email Address
(Required)
Hidden
Contact Source
News
Investor Portal
Lifestyle
Videos
Search for:
Search
More
Contact
Features
News
Home
Biotech
Investment
Diagnostics
Agetech
Supplements
Innovation
AI/Digital
Economy
The new fluoride? FDA greenlights rapamycin oral health trial
Trial to evaluate rapamycin in periodontal disease gets FDA go-ahead – Matt Kaeberlein’s Optispan to monitor aging biomarkers.
Innovation
It’s time to establish gold standards in longevity medicine
Economy
‘There will be a point where we solve aging – this decade is that moment in time’
Videos
New longevity app draws on decades of precision medicine data
AI/Digital
Diagnostics
Stanford organ aging study spawns new longevity startup
Biotech
Innovation
Insilico announces first-in-human study for oral PHD inhibitor for IBD
Biotech
NIH-funded longevity study shows astaxanthin extends lifespan
Supplements
Interface Bio emerges with $3m to harness the microbiome against inflammation
Biotech
Investment
Investment
What are the predictors of cardiovascular aging?
Features
Biolexis lands $10m to advance metabolic drug program with longevity potential
Biotech
Investment
Investment
Your perspectives on longevity clinics
Economy
Occuity ramps up IP for early detection of diseases through the eye
Diagnostics
Hevolution pumps another $40 million into aging research projects
Innovation
Investment
Investment
Most Popular
‘There will be a point where we solve aging – this decade is that moment in time’
Videos
Biolexis lands $10m to advance metabolic drug program with longevity potential
Biotech
Investment
Investment
Interface Bio emerges with $3m to harness the microbiome against inflammation
Biotech
Investment
Investment
Your perspectives on longevity clinics
Economy
Innovation
The new fluoride? FDA greenlights rapamycin oral health trial
Trial to evaluate rapamycin in periodontal disease gets FDA go-ahead – Matt Kaeberlein’s Optispan to monitor aging biomarkers.
Stanford organ aging study spawns new longevity startup
Biotech company Teal Omics founded after researchers develop algorithm that measures how fast individual organs are aging.
Hevolution pumps another $40 million into aging research projects
Aging research organizations including the Buck and AFAR benefit as Global Healthspan Summit funding commitments reach $100m.
Could XPRIZE Healthspan deliver the ‘holy grail’ for longevity science?
XPRIZE exec director Dr Jamie Justice on how the $101m competition can deliver a lasting legacy to the longevity field.
Economy
It’s time to establish gold standards in longevity medicine
Your perspectives on longevity clinics
Vitalia pop-up city aims to redefine the longevity biotech landscape
Could XPRIZE Healthspan deliver the ‘holy grail’ for longevity science?
Hevolution event set to boost global healthspan engagement
Inaugural Global Healthspan Summit set to accelerate scientific progress for a rapidly aging world
Supplements
NIH-funded longevity study shows astaxanthin extends lifespan
Research from Interventions Testing Program on astaxanthin represents advance in longevity supplements field.
Supplements
Delivering the goods – getting the best out of NMN supplements
Supplements
NIH study shows elevating NAD+ with NR supplementation effectively reduces inflammation
Supplements
Fatty acid C15:0 throws its hat into the longevity therapeutics ring
Supplements
Fatty acid discovery is a fluke for longevity
Supplements
Insilico and SRW partner to advance longevity science through power of AI
Supplements
First global urolithin A summit set to highlight latest aging research
Supplements
ChromaDex and Zesty Paws team up on cellular health for dogs
Supplements
Are supplements the key to unlocking healthy longevity?
Supplements
Editor's pick
‘There will be a point where we solve aging – this decade is that moment in time’
Videos
Will proteomics provide the answers to aging and longevity?
Biotech
Don’t wait for longevity drugs – take action today
Diagnostics
Economy
Scientific leaders issue global Dublin Longevity Declaration
Economy
Investment
Interface Bio emerges with $3m to harness the microbiome against inflammation
AI-powered platform identifies bacterial natural products with the potential to modulate the immune system and reduce inflammation.
Biolexis lands $10m to advance metabolic drug program with longevity potential
AI-powered drug discovery company is developing metabolic drug candidates targeting obesity, diabetes and human longevity.
Hevolution pumps another $40 million into aging research projects
Aging research organizations including the Buck and AFAR benefit as Global Healthspan Summit funding commitments reach $100m.
XPRIZE Healthspan offers $101m prize for successful longevity therapeutic
Winners will need to demonstrate their longevity therapy can restore muscle, cognition, and immune function by up to 20 years.
Diagnostics
New longevity app draws on decades of precision medicine data
Occuity ramps up IP for early detection of diseases through the eye
Over 30? Time to get proactive about health, longevity and disease prevention
Haut.AI raises €2m to expand skincare B2B SaaS
Aqtual bags $16m for precision medicine platform, initiates rheumatoid arthritis trial
Don’t wait for longevity drugs – take action today
Watch now
‘There will be a point where we solve aging – this decade is that moment in time’
XPRIZE founder Peter Diamandis on the biggest prize the world has ever seen – and why a successful outcome will mean we'll all be winners.
Videos
‘Our vision statement is clear: Expand healthy lifespan for the benefit of all’
Videos
Improving healthspan and longevity can be just like riding a bike
Videos
‘The longevity revolution has the potential to transform healthcare in our lifetime’
Videos
‘We all play don’t die every day – now let’s get really, really good at it’
Videos
Going for gold: new International Roundtable aims to set gold standard for longevity clinics
Videos
How sports medicine can maximize the longevity runway
Videos
Are supplements the key to unlocking healthy longevity?
Videos
‘It’s worth the hype – longevity is going to explode’
Videos
Agetech
Physicians want AI tech to help dementia patients live longer
Two-thirds of UK GPs want to prescribe tech for their dementia patients to help them remain independent and live longer.
Connected technologies are changing the future of aging at home
Huong Le Dieu, Lead Product Manager of BLabs at Baracoda Daily Healthtech, on why it's time to take aging in place to the next level.
AI innovations to transform living with dementia awarded £1.9 million
Longitude Prize on Dementia champions personalized tech that to helps people living with dementia enjoy independent and fulfilled lives.
Clearday and Viveon Health SPAC announce merger agreement to accelerate innovative longevity tech
Definitive merger agreement set to accelerate robotic companion care/AI longevity tech platform to market.
Biotech
Stanford organ aging study spawns new longevity startup
Insilico announces first-in-human study for oral PHD inhibitor for IBD
Interface Bio emerges with $3m to harness the microbiome against inflammation
Biolexis lands $10m to advance metabolic drug program with longevity potential
Loyal gets promising FDA feedback on lifespan extension drug for dogs
Merck bolsters neurodegeneration program with Caraway acquisition
AI/Digital
New longevity app draws on decades of precision medicine data
The war of the rings: Oura sues Ultrahuman
Haut.AI raises €2m to expand skincare B2B SaaS
Forward raises $100m to roll out AI-powered doctor’s office